4//SEC Filing
Johnson Philip L 4
Accession 0001765581-25-000012
CIK 0001232524other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:24 PM ET
Size
7.1 KB
Accession
0001765581-25-000012
Insider Transaction Report
Form 4
Johnson Philip L
EVP & Chief Financial Officer
Transactions
- Award
Ordinary Shares
2025-02-27+15,407→ 43,505 total - Award
Ordinary Shares
2025-02-27+7,704→ 51,209 total
Footnotes (3)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
- [F2]The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 29, 2024.
- [F3]These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0002013156
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 7:24 PM ET
- Size
- 7.1 KB